International Journal of Molecular Sciences · 2020 · 18 citations · 37 references
MedicineImmunologyPharmacologyImmunopathologyImmunopharmacologyInflammationCytokine BiologyImmunopathology Of SkinSphingolipid MetabolismNaive T CellsPsoriasis ImmunopathologyPsoriasis ModelsPsoriasis TherapyPsoriatic DiseaseSelectivityTh17 Cell DifferentiationTopical Application
Sphingosine kinases (SK) catalyze the phosphorylation of sphingosine to generate sphingosine-1-phosphate. Two isoforms of SK (SK1 and SK2) exist in mammals. Previously, we showed the beneficial effects of SK2 inhibition, using ABC294640, in a psoriasis mouse model. However, ABC294640 also induces the degradation of SK1 and dihydroceramide desaturase 1 (DES1). Considering these additional effects of ABC294640, we re-examined the efficacy of SK2 inhibition in an IMQ-induced psoriasis mouse model using a novel SK2 inhibitor, HWG-35D, which exhibits nM potency and 100-fold selectivity for SK2 over SK1. Topical application of HWG-35D ameliorated IMQ-induced skin lesions and normalized the serum interleukin-17A levels elevated by IMQ. Application of HWG-35D also decreased skin mRNA levels of interleukin-17A, K6 and K16 genes induced by IMQ. Consistent with the previous data using ABC294640, HWG-35D also blocked T helper type 17 differentiation of naïve CD4+ T cells with concomitant reduction of SOCS1. Importantly, HWG-35D did not affect SK1 or DES1 expression levels. These results reaffirm an important role of SK2 in the T helper type 17 response and suggest that highly selective and potent SK2 inhibitors such as HWG-35D might be of therapeutic use for the treatment of psoriasis.
37
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Roberto Lande, Elisabetta Botti, Camilla Jandus et al. · Nature Communications · 2014 · 534 citations · Full text
T Cells Involved in Psoriasis Vulgaris Belong to the Th1 Subset
Michael Buslau, Wolfram Jochum, E Hermann et al. · Journal of Investigative Dermatology · 1994 · 461 citations